marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 11-16-2024
AstraZeneca PLC Income Statement 2011-2024 | AZN
Annual Income Statement AstraZeneca PLC
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | 81.2 B | 126 B | 118 B | 83.5 B | 76.9 B | 68.5 B | 81.5 B | 89.7 B | 80.2 B | 62.8 B | 65.1 B |
Shares |
- | - | 1.42 B | 2.6 B | 2.6 B | 2.53 B | 2.53 B | 2.53 B | 2.53 B | 2.52 B | 2.5 B | 2.52 B | 2.72 B |
Historical Prices |
65.7 | 68.3 | 57.3 | 48.4 | 45.3 | 32.9 | 30.4 | 22.5 | 25.4 | 25.4 | 21.8 | 15.6 | 14.7 |
Net Income |
- | - | 115 M | 3.2 B | 1.34 B | 2.16 B | 3 B | 3.5 B | 2.82 B | 1.23 B | 2.56 B | 6.3 B | 9.98 B |
Revenue |
45.8 B | 44.4 B | 37.4 B | 26.6 B | 24.4 B | 22.1 B | 22.5 B | 23 B | 24.7 B | 26.1 B | 25.7 B | 28 B | 33.6 B |
Cost of Revenue |
- | - | 12.4 B | 5.3 B | 4.92 B | 4.94 B | 4.32 B | 4.13 B | 4.65 B | - | - | - | - |
Gross Profit |
37.5 B | 32 B | 25 B | 21.3 B | 19.5 B | 17.2 B | 18.1 B | 18.9 B | 20.1 B | 20.3 B | 20.4 B | 22.6 B | 27.6 B |
Operating Income |
- | - | 1.06 B | 5.16 B | 2.92 B | 3.39 B | 3.68 B | 4.9 B | 4.11 B | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | 1.06 B | 5.16 B | 2.92 B | 3.39 B | 3.68 B | 3.66 B | 3.25 B | 2.32 B | 3.84 B | 8.24 B | 13.1 B |
Operating Expenses |
- | - | - | 17.6 B | 17.8 B | 15.6 B | 15.9 B | 15.3 B | 16.9 B | 18.1 B | 16.8 B | 14.4 B | 17 B |
General and Administrative Expenses |
- | - | 15.2 B | - | - | - | 10.2 B | - | - | - | - | 9.84 B | 11.2 B |
All numbers in USD currency
Quarterly Income Statement AstraZeneca PLC
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | 1.32 B | - | - | - | 1.31 B | - | - | - | 1.31 B | - | - | - | 1.27 B | - | - | - | 1.27 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | - | - | - | 550 M | - | - | - | 738 M | - | - | - | 107 M | - | - | - | 319 M | - | - | - | 446 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | 8.22 B | - | - | - | 6.28 B | - | - | - | 5.82 B | - | - | - | 5.16 B | - | - | - | 5.05 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | 2.19 B | - | - | - | 984 M | - | - | - | 1.06 B | - | - | - | 1.01 B | - | - | - | 950 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 6.03 B | - | - | - | 5.29 B | - | - | - | 4.76 B | - | - | - | 4.14 B | - | - | - | 4.1 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | 1.13 B | - | - | - | 1.28 B | - | - | - | 493 M | - | - | - | 763 M | - | - | - | 925 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | 1.13 B | - | - | - | 1.28 B | - | - | - | 493 M | - | - | - | 763 M | - | - | - | 925 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | 3.1 B | - | - | - | 2.64 B | - | - | - | 2.94 B | - | - | - | 2.55 B | - | - | - | 2.36 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency